Cyfuse Biomedical KK Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Cyfuse Biomedical KK

Watchlist Manager

Watchlist

Price: 516 JPY -1.34% Market Closed

Market Cap: ¥5.2B

C	Cyfuse Biomedical KK TSE:4892	JP
S	Schneider Electric SE XBER:SND	FR
A	American Water Works Company Inc F:AWC	US
V	VF Corp XBER:VFP	US
	Theon International Plc F:W8C	CY
F	Fagron NV XBER:4A5	BE
	Tubacex SA LSE:0KD1	ES
B	Brilliant Earth Group Inc NASDAQ:BRLT	US
	Immutep Ltd ASX:IMM	AU
C	Carlisle Companies Inc DUS:CLE	US

Profitability Summary

Cyfuse Biomedical KK's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

51%

Strong 3Y Average Gross Margin

50%

Declining Gross Margin

65% > 51%

Negative Operating Margin

-342%

Negative 3Y Average Operating Margin

-1 119%

Operating Margin is Increasing

-1 150% > -342%

Negative Net Margin

-351%

Negative 3Y Average Net Margin

-1 053%

Net Margin is Increasing

-1 201% > -351%

Negative Free Cash Flow Margin

-248%

Negative 3Y Average Free Cash Flow Margin

-793%

Negative ROE

-31%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-191%

ROIC is Increasing

-215% > -160%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.